Companies / Viking Therapeutics Inc
Viking Therapeutics Inc
Nasdaq: VKTXCIK 1607678SAN DIEGO, CA
Financials · FY2025
Ownership
116.7M shares outstanding · as of Jul 15, 2026
Ownership
| Insiders | 2.50% | 2,921,283 |
| Institutions | 65.47% | 76,372,662 |
| Public float | 32.03% | 37,358,992 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 10
View all →| Insider | % of shares | Shares |
|---|---|---|
Lian BrianCEOPresident & CEO · Director | 2.14% | 2,499,291 |
Mancini MariannaFormerChief Operating Officer | 0.35% | 409,190 |
Zante GregChief Financial Officer | 0.16% | 189,891 |
Foehr Matthew WDirector | 0.12% | 135,186 |
Macartney LawsonDirector | 0.04% | 51,115 |
Rowland Charles A JrDirector | 0.03% | 33,150 |
Singleton J MatthewDirector | 0.01% | 12,650 |
Aubuchon Neil WilliamFormerChief Commercial Officer | <0.01% | 4,475 |
Rouan Sarah KathrynFormerDirector | <0.01% | 4,390 |
Kelly-Gemmell Dorothy ElizabethFormerDirector | — | — |
Institutional holders 438
View all →| Holder | Value | % of shares |
|---|---|---|
| $351.25M | 8.56% | |
| $241.46M | 5.31% | |
| $230.70M | 5.62% | |
| $218.71M | 4.81% | |
| $144.22M | 3.80% | |
| $108.22M | 2.64% | |
| $74.91M | 1.83% | |
| $67.77M | 1.78% | |
| $60.95M | 1.49% | |
| $54.56M | 1.44% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Lian Brian CEO | Sell | Common Stock, par value $0.00001 per share | $4.28M | -132K -4.85% | 2,600,246 2.23% of shares | medium |
| Jan 5, 2026 | Lian Brian CEO | Sell | Common Stock, par value $0.00001 per share | $1.78M | -53K -2.05% | 2,546,967 2.18% of shares | medium |
| Jan 5, 2026 | Lian Brian CEO | Sell | Common Stock, par value $0.00001 per share | $1.41M | -41K -1.62% | 2,505,691 2.15% of shares | medium |
| Jan 5, 2026 | Zante Greg Executive | Sell | Common Stock, par value $0.00001 per share | $1.03M | -32K -12.91% | 215,571 0.18% of shares | medium |
| Jan 5, 2026 | Mancini Marianna Executive | Sell | Common Stock, par value $0.00001 per share | $1.03M | -32K -6.85% | 434,890 0.37% of shares | medium |
| Jan 2, 2026 | Foehr Matthew W Director | Sell | Common Stock, par value $0.00001 per share | $561.7K | -16K -10.81% | 132,036 0.11% of shares | medium |
| Jan 5, 2026 | Zante Greg Executive | Sell | Common Stock, par value $0.00001 per share | $464.0K | -14K -6.45% | 201,671 0.17% of shares | medium |
| Jan 5, 2026 | Mancini Marianna Executive | Sell | Common Stock, par value $0.00001 per share | $453.9K | -14K -3.13% | 421,290 0.36% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| VKTX | — | 92686J106 |